Sökning: WFRF:(Marwa Karol) >
Lumefantrine plasma...
Lumefantrine plasma concentrations in uncontrolled conditions among patients treated with artemether-lumefantrine for uncomplicated plasmodium falciparum malaria in Mwanza, Tanzania
-
- Marwa, Karol J. (författare)
- Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania.
-
- Liwa, Anthony C. (författare)
- Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania.
-
- Konje, Eveline (författare)
- Catholic Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Mwanza, Tanzania.
-
visa fler...
-
- Mwita, Stanley (författare)
- Catholic Univ Hlth & Allied Sci, Sch Pharm, Mwanza, Tanzania.
-
- Kamugisha, Erasmus (författare)
- Catholic Univ Hlth & Allied Sci, Dept Biochem, Mwanza, Tanzania.
-
- Swedberg, Göte (författare)
- Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
-
visa färre...
-
Catholic Univ Hlth & Allied Sci, Dept Pharmacol, Mwanza, Tanzania Catholic Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Mwanza, Tanzania. (creator_code:org_t)
- Elsevier, 2022
- 2022
- Engelska.
-
Ingår i: International Journal of Infectious Diseases. - : Elsevier. - 1201-9712 .- 1878-3511. ; 123, s. 192-199
- Relaterad länk:
-
https://doi.org/10.1...
-
visa fler...
-
https://uu.diva-port... (primary) (Raw object)
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Therapeutic efficacy of artemether-lumefantrine is highly dependent on adequate systemic exposure to the partner drug lumefantrine particularly day 7 lumefantrine plasma concentration. There has been contradicting findings on the role of the cut-off values in predicting treatment outcomes among malaria patients in malaria endemic regions. This study assesses the day 3 and 7 lumefantrine plasma concentrations including related determinant factors and their influence on treatment outcomes among treated Tanzanian children and adults in uncontrolled conditions (real life condition).Methods: Data was nested from an efficacy study employing the WHO protocol, 2015 for monitoring antimalarial drug efficacy. Lumefantrine plasma concentration was measured by high performance liquid chromatography with ultraviolet (HPLC-UV).Results: Lumefantrine plasma concentrations below 175ng/ml and 20 0ng/ml on day 3 and 7 did not affect adequate clinical and parasitological response (ACPR) and recurrence of infection ( p = 0.428 and 0.239 respectively). Age and baseline parasitemia were not as-sociated to day 3 median lumefantrine plasma concentrations (p = 0.08 and 0.31 respectively) and day 7 lumefantrine plasma concentrations (p = 0.07 and 0.41 respectively). However, the day 3 and day 7 lumefantrine plasma concentrations were significantly higher in males compared to females ( p = 0.03 and 0.042 respectively).Conclusion: Lumefantrine plasma concentrations below cut-off points (175ng/ml and 20 0ng/ml) on day 3 and 7 did not influence treatment outcomes.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
Nyckelord
- Lumefantrine
- day 7 concentration
- day 3 concentration
- treatment outcomes and Tanzania
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas